Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Y Wen

Showing results (31-40 of 640) with videos related to

Pageof 64
Sort By:
Expert Review of Neurotherapeutics|November 3, 2006
Chemotherapy and targeted molecular therapies for brain metastasesJan Drappatz, Patrick Y Wen
Neuro-Oncology|January 25, 2018
The siren song of bevacizumab: swan song or clarion call?David Schiff, Patrick Y Wen
Expert Opinion on Pharmacotherapy|September 14, 2022
Current therapeutic options for glioblastoma and future perspectivesElisa Aquilanti, Patrick Y Wen
Current Neurology and Neuroscience Reports|October 9, 2023
Molecular Profiling and Targeted Therapies in GliomasYuli Felistia, Patrick Y Wen
Current Neurology and Neuroscience Reports|January 3, 2024
Updated Response Assessment in Neuro-Oncology (RANO) for GliomasGilbert Youssef, Patrick Y Wen
Neurologic Clinics|April 15, 2003
Neurologic complications of cancer. PrefacePatrick Y Wen, Michael J Glantz
Neurologic Clinics|April 15, 2003
Neurologic complications of cancer therapyScott R Plotkin, Patrick Y Wen
Current Oncology Reports|November 19, 2010
Response assessment in neuro-oncologyEudocia C Quant, Patrick Y Wen
Expert Opinion on Emerging Drugs|November 5, 2016
Emerging targeted therapies for gliomaJulie J Miller, Patrick Y Wen
Magnetic Resonance Imaging Clinics of North America|October 16, 2016
Response Assessment in Neuro-Oncology Criteria and Clinical EndpointsRaymond Y Huang, Patrick Y Wen
Pageof 64

Showing results (31-40 of 640) with videos related to

Sort By:
Pageof 64
Expert Review of Neurotherapeutics|November 3, 2006
Chemotherapy and targeted molecular therapies for brain metastasesJan Drappatz, Patrick Y Wen
Neuro-Oncology|January 25, 2018
The siren song of bevacizumab: swan song or clarion call?David Schiff, Patrick Y Wen
Expert Opinion on Pharmacotherapy|September 14, 2022
Current therapeutic options for glioblastoma and future perspectivesElisa Aquilanti, Patrick Y Wen
Current Neurology and Neuroscience Reports|October 9, 2023
Molecular Profiling and Targeted Therapies in GliomasYuli Felistia, Patrick Y Wen
Current Neurology and Neuroscience Reports|January 3, 2024
Updated Response Assessment in Neuro-Oncology (RANO) for GliomasGilbert Youssef, Patrick Y Wen
Neurologic Clinics|April 15, 2003
Neurologic complications of cancer. PrefacePatrick Y Wen, Michael J Glantz
Neurologic Clinics|April 15, 2003
Neurologic complications of cancer therapyScott R Plotkin, Patrick Y Wen
Current Oncology Reports|November 19, 2010
Response assessment in neuro-oncologyEudocia C Quant, Patrick Y Wen
Expert Opinion on Emerging Drugs|November 5, 2016
Emerging targeted therapies for gliomaJulie J Miller, Patrick Y Wen
Magnetic Resonance Imaging Clinics of North America|October 16, 2016
Response Assessment in Neuro-Oncology Criteria and Clinical EndpointsRaymond Y Huang, Patrick Y Wen
Pageof 64